ORIGINAL ARTICLE
Epilepsy is 7 times more common in patients with 22q11DS than the general population 11, 12 . Non-hypocalcemic seizures in 22q11DS patients can have generalized or partial (i.e. focal) onset. According to Kao et al, partial onset seizures affect 5.5% of all patients with 22q11DS 11 . Known potential causes of partial onset seizures in this group of patients include rare case reports of polymicrogyria (PMG) 13 , periventricular nodular heterotopia (PNH) 14 , or hippocampal atrophy (HA) 15 . However, the prevalence of these abnormalities in the 22q11DS population is low, accounting for, at most, 25% of all cases of partial onset epilepsy 11, 12 . Since there is a discrepancy between the prevalence of partial onset epilepsy and the prevalence of known causal structural abnormalities, the aim of this study was to evaluate a series of subjects with 22q11DS, using high resolution magnetic resonance imaging (MRI) and electroencephalography (EEG) to specifically search for additional findings to explain this difference.
PATIENTS AND METHODS
Patients: Nineteen adult patients with 22q11DS consecutively referred between 2009-2011 from an adult cohort enriched for neuropsychiatric disorders 4 comprised the sample for this study. Inclusion criteria: absence of other pathogenic CNVs. Exclusion criteria: seizures associated with stroke or hypocalcemia. Patients without previous history of seizures were included.
Epilepsy history and assessment was conducted by an experienced epileptologist (DA). Diagnosis of epilepsy and seizure types was made according to the classification of the International League Against Epilepsy (www.ilae.org). Electroencephalogram (EEG) studies: Patients were subjected to prolonged digital EEG recordings lasting between one and seven days. Overnight recordings were obtained either through admission to an Epilepsy Monitoring Unit or through ambulatory EEG. Digital EEG recordings were performed using the international 10-20 system in XLTEK recording equipment.
Genetic studies: 22q11.2 microdeletion was confirmed by FISH analysis using standard probes in all patients 4, 16 . All participants also had genome-wide microarray data available to exclude the presence of other pathogenic CNVs 4 . Imaging: Patients were scanned on a 3 Tesla magnetic resonance imaging (MRI) system using an eight-channel head coil. We used a dedicated seizure scanning protocol including axial and coronal high resolution T1 IR (TE/TR/TI: 42/6500/170ms; 3mm slice thickness, 512x512 Matrix) and T2 FLAIR (TE/TR/IR/: 136/8650/2250ms, 4mm slice thickness, 384x224 Matrix ) sequences. Coronal sequences were angulated perpendicular to the hippocampi and caution was taken to All patients with schizophrenia (SZ) or other psychotic illnesses were receiving antipsychotic medications. Patients with major depression and/or anxiety disorders were receiving antidepressant/antianxiety medications. All patients were either treated for documented hypocalcemia or received prophylactic vitamin D and calcium supplements for the elevated risk of hypocalcemia in 22q11DS.*: hipocampal atrophy; **: focal scarring over right mid-temporal gyrus; : psychosis not otherwise specified; 2 o GTCS: secondarily generalized tonic-clonic seizures; ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum disorder; BA: background activity; BF: bi-frontal; BPQ: both posterior quadrants; BT: bi-temporal; CPS: complex partial seizures; EEG: electroencephalogram; G: generalized; GAD: generalized anxiety disorder; G-PSW: generalized polyspike and waves; GTCS: generalized tonic-clonic seizures; HIMAL: hippocampal malrotation; IED: interictal epileptiform discharges; IS: intermittent slowing; LFC: left fronto-central; LFH: left frontal horn MD: major depression; MRI: magnetic resonance imaging; MS: myoclonic seizures; N: Normal; OCD: obsessive compulsive disorder; PMG: polymicrogyira; PNH: periventricular nodular heterotopia; RFH: right frontal horn; RT: right temporal; S: slow; SZ: schizophrenia, WM: white matter. 
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Patients with epilepsy quality MRI and no correlation to structural abnormalities could be made. One patient with IEDs over both frontal and temporal regions had PNH over the left frontal horn and widespread PMG over the right hemisphere.
Structural abnormalities: Five patients moved or were claustrophobic during the MRI study. Therefore we had MRI of sufficient quality for 14 patients. Structural abnormalities that were previously described in patients with 22q11DS were seen in our group at the following rates: mild to moderate generalized atrophy in seven; PMG in one and PNH in three patients (the patient with PMG also had PNH). Focal scaring over the middle temporal gyrus in one patient. One patient had HA, without abnormal MRI signal, volume loss of the temporal white matter, or atrophy of the fornix or ipsilateral mammillary bodies to support the diagnosis of hippocampal sclerosis.
However, in addition to the abnormalities previously described in the literature, we found HIMAL in nine (64%) of the 14 patients with 22q11DS and good quality imaging ( Figure  1) . Of the three patients with malformations of cortical development (PMG and PNH), two also had HIMAL (66%). Of the 10 patients without epilepsy, six had HIMAL (60%). Of the four patients with epilepsy and good quality MRI, three had HIMAL (75%) (Figure 2 ) [17] [18] [19] [20] [21] . Although this study was designed to look for causes of epilepsy in the 22q11DS population, we observed HIMAL in 50% of the patients with schizophrenia and 41% of those with mild or borderline intellectual disability.
DISCUSSION
Chromosome 22q11.2 microdeletion leads to a complex phenotype with several neurological problems. Different structural abnormalities have been described in this population: generalized brain atrophy 22 , reduced volumes of parietal and temporal lobes 23 , hippocampus 24 , cerebellum and vermis 25 , and thalami 26 , as well as basal ganglia hypertrophy 27, 28 . Known structural changes that can be associated with seizures in this population include: HA 15 , PMG 13 and PNH 14 . However the low prevalence of HA, PMG and PNH in 22q11DS is insufficient to explain why up to 7% of these patients have seizures. Interestingly our results revealed for the first time, that HIMAL, a potentially epileptogenic abnormality 17, 20, 29, 30 is overrepresented in patients with this 22q11DS.
Hippocampal malrotation is a failure of the hippocampus to properly fold around the hippocampal sulcus into the temporal lobe. This process is completed by the 25th gestational week 31 . Hippocampal malrotation has been mainly described in patients with epilepsy. HIMAL was observed in 2-54% of patients with seizures associated with other developmental abnormalities, such as absence of corpus callosum, focal cortical dysplasia, hemimegalencephaly, subcortical laminar heterotopia, single or multiple unilateral or bilateral periventricular nodular heterotopia, schizencephaly, and polymicrogyria 32 . A large survey of 527 adult patients with epilepsy showed that 5% of them had HIMAL 17 . Subsequent studies observed HIMAL in 12% of patients with prolonged febrile seizures 21 ( Figure 2 ). However data on large rare CNVs were not reported for these individuals.
The incidence of HIMAL in control populations (without seizures or malformations of cortical development) has been reported to vary between 5/50 20 and 19/100 19 . However, when the stricter Barsi MRI criteria are applied 17 , Gamss and colleagues found that none of the 497 patients without seizures fulfilled all the criteria for HIMAL 18 . Using the same criteria in our cohort, HIMAL was observed in six of ten patients (60%) without seizures or malformations of cortical development and good quality MRI (6 out of 10 versus 0 out of 497, Fisher's exact p < 0.001). In those patients with epilepsy (focal or generalized, but none with "temporal lobe epilepsy") and good quality MRI, HIMAL was observed in 75% of cases. These numbers suggest that the hemizygous deletion of the 22q11.2 region predisposes to HIMAL.
We propose that HIMAL results from the haploinsufficiency of one or more genes in the 22q11.2 microdeletion region. If this is true, why do all patients with 22q11DS not have HIMAL? The phenotypic variability that can result from a shared genetic abnormality may be explained by modulatory effects of other variants located elsewhere in the genome. Alternatively, the hemizygosity may unmask a recessive mutation in the other 22q11.2 allele. Other possibilities have also been proposed for phenotypic variability in 22q11DS 33 . Despite some statistical evidence of the association between HIMAL and epilepsy, the mechanism by which HIMAL leads to or is associated with epilepsy is not well understood. HIMAL is probably not the single reason leading to the development of seizures. However it can be a "first hit" that, in conjunction with other genetic or non-genetic factors may act in concert for the development or maintenance of seizures 29 . HIMAL has also been associated with complex pre-frontal dysfunction in children with epilepsy 34 and has been observed in adults with schizophrenia 35 . Whether or not HIMAL is also associated with the other neuropsychiatric conditions seen in 22q11DS, e.g., intellectual disability, remains to be determined.
Temporal lobe and specifically hippocampal abnormalities have been previously described in patients with 22q11DS, however HIMAL has never been reported in this population. We believe the reason for this is that HIMAL is much better appreciated with the imaging protocol used in this study. This is a protocol designed for patients with temporal lobe epilepsy and therefore the coronal images on the 3 Tesla magnet allow better resolution and thus identification of this abnormality.
Limitations: The population studied here were from an adult 22q11DS cohort enriched for neuropsychiatric conditions 4 . All these patients were initially seen in the psychiatry clinic and then referred to the epilepsy clinic. This may explain the higher prevalence of seizure disorders (26%) in our study compared to a large group of unselected younger patients with 22q11DS (7% in Kao and others 2004) . Despite this, the prevalence of HIMAL observed was much higher than in patients with other forms of epilepsy or febrile seizures, both of which also represent preselected populations. It will be important to study a larger, randomly selected group of patients with 22q11DS with a similar MRI protocol to determine the overall prevalence of HIMAL. Another limitation is that this study was designed to determine the causes of seizures. Therefore the potential relationship between HIMAL and other neuropsychiatric abnormalities such as learning disabilities or schizophrenia will require further studies.
CONCLUSION
Hippocampal malrotation is overrepresented in patients with 22q11DS. Although HIMAL has been previously associated with seizures, its presence in 60% of 22q11DS patients without seizures (and 75% of those with seizures) suggest that other factors, as yet unknown, are also contributing to the increased epileptogenesis seen in this population. The role of HIMAL in the other neuropsychiatric abnormalities seen in this population will require further study.
